Login

Lost your password?
Don't have an account? Sign Up
Dec 27, 2022

New AI-technology could help early detection of breast cancer

In 2020, breast cancer amounted for 13,3 percent of newly diagnosed cancer cases in the European Union making it the most frequently occurring cancer type in the EU. On average, one in eleven European women develops breast cancer before the age of 74. An Indian Start-Up has now developed a new device that

Dec 23, 2022

Resurrecting Climate-Resilient Rice in India

Seemingly miraculous varieties that can withstand drought, flood, and saltwater intrusion are the result of centuries of selective breeding by ancient farmers. Until as recently as 1970, India was a land with more than 100,000 distinct varieties of rice. Across a diversity of landscapes, soils, and climates, native rice varieties, also called “landraces,”

Dec 23, 2022

Opinion: How China can boost Southeast Asia’s energy transition

China can help ASEAN countries reconfigure their electricity systems around renewable energy by sharing its own experiences Southeast Asia is today one of the world’s most economically dynamic regions, maintaining annual per capita GDP growth of over 3.5% in the decade up to the pandemic, higher than the US, Japan and Europe. Rapid

Dec 23, 2022

Why Congress Can’t Stop the CIA From Working With Forces That Commit Abuses

by Lynzy Billing ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. For more than two decades, the U.S. military has been barred from providing training and equipment to foreign security forces that commit “gross violations of internationally recognized

Dec 22, 2022

Buying the Final Frontier

Outer space was supposed to belong to all humankind. Should we surrender it to anyone who can pay up? By Philip Ball Hands up: Who thought it was cool that Captain James T. Kirk (aka Canadian actor William Shatner) got to go into space for real at the age of 90—and, at the

Dec 21, 2022

The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice

Rachana Pradhan December 2, 2022 After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials. To bring a new